Real-World Effectiveness and Safety of Finerenone in People With Type 2 Diabetes and Chronic Kidney Disease: A Spanish Multicentre Retrospective Observational Study (MEDFINE-RWD)

Diabetes Obes Metab. 2026 Jul 30. doi: 10.1111/dom.71160. Online ahead of print.ABSTRACTAIM: Although finerenone has shown efficacy in randomized trials, evidence from routine clinical practice remains limited. We aimed to assess the real-world effectiveness and safety of finerenone in people with t

O Oscar Moreno-Pérez

Sugar and artificial sweeteners and risk of cardiovascular disease

Eur J Intern Med. 2026 Jul 30:107090. doi: 10.1016/j.ejim.2026.107090. Online ahead of print.ABSTRACTHumans have an innate preference for sweetness; in this regard, dietary sugar consumption patterns are established early in life. Although moderate consumption of naturally occurring sugars from whol

A Antonis A Manolis

Preventing the next stroke: nurse-led decision and adherence coaching to empower people with stroke (StrokeCompass) versus usual care - study protocol for a stepped-wedge pilot trial

BMJ Open. 2026 Jul 30;16(7):e116718. doi: 10.1136/bmjopen-2026-116718.ABSTRACTINTRODUCTION: Recurrent stroke prevention is important for people who have suffered a stroke or transient ischaemic attack (TIA), as they are at increased risk of having another stroke. Nevertheless, treatment adherence is

J Jasmin Helbach

Effects of Short-term High-intensity vs. Moderate-intensity Interval Training on Cardiopulmonary Fitness and Metabolic Health in Overweight or Obese Patients with Cardiovascular Disease: Evidence from China

Arch Phys Med Rehabil. 2026 Jul 30:S0003-9993(26)00851-8. doi: 10.1016/j.apmr.2026.07.020. Online ahead of print.ABSTRACTOBJECTIVE: Overweight or obese patients with cardiovascular disease (CVD) often exhibit reduced cardiopulmonary fitness and increased cardiometabolic risk. This study aimed to com

J Jinna Chang